James R. Mcilroy
Bellshill, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0.
Journal: Advances in experimental medicine and biology
Published: January 04, 2024
The Unique Impact of COVID-19 on Human Gut Microbiome Research.
Journal: Frontiers in medicine
Published: January 13, 2021
Letter: intestinal microbiota transfer-updating the nomenclature to increase acceptability.
Journal: Alimentary pharmacology & therapeutics
Published: October 21, 2020
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 21, 2020
Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products.
Journal: United European gastroenterology journal
Published: March 28, 2020
Faecal Microbiota Transplantation as Emerging Treatment in European Countries.
Journal: Advances in experimental medicine and biology
Published: February 01, 2018
Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK.
Journal: Frontline gastroenterology
Published: November 26, 2017
Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
Journal: Alimentary pharmacology & therapeutics
Published: May 05, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026